Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2007-11-20

Clinical Trial Update: The Anti-Diabetic and Cholesterol-Lowering Effects of Cinnamon and Cassia Bark [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating whether cinnamon and cassia bark can improve glycemic control and lower cholesterol in people with type 2 diabetes and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cassia bark
  • Cinnamon (cinnamon)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Type 2 Diabetes, Hypercholesterolemia | Phase 2 | Status: UNKNOWN